SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Evoq Remedies informs about disclosure

20 Feb 2025 Evaluate
Evoq Remedies has informed that Demand Notice under Section 74 under GST Act, Wide Order no. 148 dated 28.01.2025 has been came to knowledge via GST portal on 20th February, 2025. Considering the materiality of the said event, the Company discloses this event as ‘pending actions which may have an impact on the listed entity’. The Company would be reviewing the order and taking all necessary steps to take this to the logical conclusion and safeguard the interests of Company and stakeholders at large.

The above information is a part of company’s filings submitted to BSE.

EVOQ Remedies Share Price

2.90 0.07 (2.47%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 229.90
Amrapali Industries 30.39
Adani Enterprises 2930.05
Rashi Peripheral 529.50
PDS 301.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×